Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Edico Genome And InterSystems Partner To Streamline Clinical Next-Generation Sequencing Workflows

Edico Genome
Posted on: 28 Feb 18

SAN DIEGO and CAMBRIDGE, Mass., Feb. 26, 2018 /PRNewswire/ -- Edico Genome and InterSystems today announced a new partnership to integrate Edico Genome's DRAGEN Clinical Genomics Information System (CGIS) into the broader healthcare ecosystem. This partnership expands Edico Genome's existing agreements with leading tertiary analysis providers and leverages the world-class healthcare IT solutions and expertise of InterSystems to allow physicians to easily order a genomic test at point of care and enable comprehensive data analysis through seamless exchange of clinical and genomic information across the entire patient electronic medical record (EMR).

Through this partnership, DRAGEN CGIS will leverage the power of InterSystems' HealthShare HealthConnect to exchange and communicate genetic information in a bi-directional manner. This will enable the harmonization of big data generated by next-generation sequencing (NGS) within the context of the broader healthcare information technology (IT) ecosystem, ensuring patient data is fully integrated when reviewing an individual's genomic profile. By integrating data from patient's records into the NGS workflow, interpretation of genomic insights can be more confidently assessed given the richer clinical and phenotypic context available. 

Health Connect is a next-generation interoperability platform designed specifically for the demands of today's healthcare environment. The platform delivers the high-volume transaction support, unparalleled process management and continuous monitoring required for the "always on" business of healthcare.

"Our goal is to make it as simple and seamless as possible for labs of all sizes to start using NGS in routine clinical care, and DRAGEN is fundamental in making this economically feasible," said Pieter van Rooyen, Ph.D., president and chief executive officer at Edico Genome. "Through our partnership with InterSystems, we are able to seamlessly integrate DRAGEN CGIS into the broader healthcare ecosystem day-to-day workflow and operations, enabling patients' genetic and clinical data to be easily reviewed together and potentially leading to richer insights."

Edico Genome's CGIS is a comprehensive clinical genomics system designed to enable clinical labs to quickly and efficiently develop laboratory-developed tests (LDTs). DRAGEN CGIS integrates Edico Genome's Complete Suite of Somatic, Germline, Joint Genotyping and RNA Gene Fusion pipelines with upstream and downstream partnerships, including with Fabric Genomics, to offer a complete out-of-the-box, go-to-market solution for developing sequencing-based LDTs. DRAGEN CGIS encompasses sample accessioning from start to finish, including lab tracking, secondary and tertiary analysis of NGS data, EMR integration, test kit offerings and an implementation starters toolkit.

"Next-generation sequencing is a key frontier of medicine, and we are proud to support Edico Genome's leading-edge work in this area," said Paul Grabscheid, vice president of strategy for InterSystems. "By ensuring seamless connectivity between a patient's genomic testing and their longitudinal health record, this partnership will give clinicians and patients alike better visibility into their complete health."

About InterSystems

InterSystems is the engine behind the world's most important applications. In healthcare, finance, government, and other sectors where lives and livelihoods are at stake, InterSystems is the power behind what matters™. Founded in 1978, InterSystems is a privately held company headquartered in Cambridge, Massachusetts (USA), with offices worldwide, and its software products are used daily by millions of people in more than 100 countries. For more information, visit

About Edico Genome

Edico Genome is the leading secondary analysis solution provider for next-generation sequencing, delivering its powerful DRAGENTM Bio-IT platform to clinical, research and genome centers around the globe. Leveraging field-programmable gate array (FPGA) technology, DRAGEN delivers best-in-class accuracy, speeds, scalability and costs, enabling customers of all sizes to focus on what matters most – delivering breakthrough results. The comprehensive set of DRAGEN pipelines can be run onsite, in the Cloud or through a seamless hybrid cloud blend, allowing organizations to scale as their throughput fluctuates. Edico Genome has set two GUINNESS WORLD RECORDSTM titles for its speed, and received top marks for its accuracy in the recent PrecisionFDA Challenge. For more information about DRAGEN, visit

Editor's Details

Mike Wood

Last updated on: 28/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.